Ashutosh Raina
Neurology with Special Qualifications in Child Neurology · Rocklin, CANPI 1477787794
Payments from drug & device makers
Across 779 payments — averaging $15.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$3K
- Tris Pharma Inc$2K
- Supernus Pharmaceuticals, Inc.$989
- Corium, LLC$819
- SK Life Science, Inc.$642
- Jazz Pharmaceuticals Inc.$523
- plus $4K from 29 others
What the payments were for
- Food & beverage$12,099100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 187 | $2,707 |
| Tris Pharma Inc | 145 | $2,332 |
| Supernus Pharmaceuticals, Inc. | 66 | $989 |
| Corium, LLC | 58 | $819 |
| SK Life Science, Inc. | 45 | $642 |
| Jazz Pharmaceuticals Inc. | 29 | $523 |
| Sunovion Pharmaceuticals Inc. | 49 | $512 |
| Eisai Inc. | 27 | $480 |
| Neurelis, Inc. | 30 | $453 |
| Sumitomo Pharma America, Inc. | 18 | $324 |
| Collegium Pharmaceutical, Inc. | 22 | $267 |
| Greenwich Biosciences, Inc. | 15 | $247 |
| Aquestive Therapeutics, Inc. | 13 | $246 |
| Ironshore Pharmaceuticals Inc. | 11 | $222 |
| Acadia Pharmaceuticals Inc | 8 | $212 |
| Neos Therapeutics, LP | 11 | $177 |
| Livanova USA, Inc. | 7 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $131 |
| Zimmer Biomet | 1 | $113 |
| Zogenix Inc. | 4 | $79 |
| Adlon Therapeutics L.p. | 3 | $63 |
| Cranial Technologies, Inc | 3 | $47 |
| Immedica Pharma US, Inc. | 2 | $46 |
| AstraZeneca(2 entities) | 3 | $45 |
| Biogen | 2 | $44 |
| Azurity Pharmaceuticals, Inc. | 2 | $44 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $44 |
| Ultragenyx Pharmaceutical Inc. | 2 | $36 |
| Biomarin Pharmaceutical Inc. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| ITF Therapeutics LLC | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $22 |
| Biocodex, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $13 |
| Brainscope Company, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,117 in reported general payments places this provider in the 65th percentile of 216 neurology with special qualifications in child neurology providers in California.
See all neurology with special qualifications in child neurology providers in California →
Other neurology with special qualifications in child neurology in Rocklin
- Sabine MuellerSan Francisco$17.5M
- Joseph SullivanSan Francisco$1.7M
- Rajsekar RajaramanLos Angeles$1.5M
- Jonathan SantoroPalo Alto$1.5M
- Michelle MonjePalo Alto$1.3M
- Jay DesaiLos Angeles$1.2M
- Richard HaasSan Diego$1.2M
- Leigh Maria Ramos PlattLos Angeles$981K
- Agnes ChenTorrance$792K
- Wendy MitchellLos Angeles$749K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.